Skip to content

Clinical trials

Bone Marrow Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Marrow Diseases Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20061
20073
20103
20114
20125
20135
20147
20155
20161
20173
20181
20192
20201
20212
20221
20236
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated10
Recruiting8
Active, not recruiting5
Unknown status4
Not yet recruiting2
Withdrawn1
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
National Heart, Lung, and Blood Institute (NHLBI)4
Ariad Pharmaceuticals3
Groupe Francophone des Myelodysplasies3
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Cellenkos, Inc.2
Center for International Blood and Marrow Transplant Research2
Shandong University2
Sierra Oncology LLC - a GSK company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Marrow Diseases65
Hematologic Diseases39
Myeloproliferative Disorders25
Myelodysplastic Syndromes22
Leukemia20
Anemia13
Primary Myelofibrosis13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12
Leukemia, Myeloid12
Neoplasms12

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.